Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tampa, FL
NPI
1306192976
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
13330 Usf Laurel Dr
Tampa, FL, 33612
Phone (813) 974-2201
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
465 services
Medicare patients, 2024
160
Average age 66
Drug cost, 2024
$970K
1,600 prescriptions
Company payments, 2025
$327
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bayan Mesmar was code 99214 (office e&m - established), 141 times for 81 patients. In total Bayan Mesmar billed 465 services in 21 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 141 | 81 | $88.06 | $12K |
| 83036 Blood Count | Office | 84 | 50 | $9.52 | $800 |
| 95251 Test - Miscellaneous | Office | 67 | 35 | $25.17 | $1,686 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 17 | $92.09 | $3,131 |
| 99215 Office E&M - Established | Office | 32 | 31 | $113.59 | $3,635 |
| 99221 Hospital E&M - Initial | Facility | 31 | 30 | $64.05 | $1,986 |
| 82962 Clinical Chemistry | Office | 19 | 17 | $3.21 | $60.99 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 15 | $12.78 | $205 |
| 99213 Office E&M - Established | Office | 11 | 11 | $41.09 | $452 |
By year: 2022 $29K for 441 services; 2023 $30K for 482 services; 2024 $27K for 465 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 84 | 50 | $9.52 | $800 |
| 82962 Clinical Chemistry | 19 | 17 | $3.21 | $60.99 |
Medicare prescription drug claims, 2024
In 2024, the drug Bayan Mesmar prescribed most often to Medicare patients was Levothyroxine Sodium, with 152 prescriptions and refills. In total Bayan Mesmar wrote 1,600 Medicare prescriptions that cost $970K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 152 | 376 | 41 | $1,303 |
| Mounjaro Tirzepatide | 135 | 149 | 20 | $155K |
| Ozempic Semaglutide | 118 | 191 | 29 | $176K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 100 | 218 | 32 | $11K |
| Hydrocortisone Generic | 59 | 111 | 16 | $3,487 |
| Synthroid Levothyroxine Sodium | 55 | 143 | 16 | $6,209 |
| Novolog Flexpen Insulin Aspart | 43 | 88 | 20 | $9,914 |
| Trulicity Dulaglutide | 41 | 61 | Under 11 | $57K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 37 | 89 | 14 | $4,827 |
| Metformin Hcl Er Metformin Hcl | 36 | 99 | 14 | $131 |
| Atorvastatin Calcium Generic | 36 | 104 | 14 | $179 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 29 | 43 | Under 11 | $3,088 |
| Methimazole Generic | 27 | 63 | Under 11 | $185 |
| Alendronate Sodium Generic | 27 | 74 | Under 11 | $356 |
| Humalog Kwikpen U-100 Insulin Lispro | 26 | 73 | 13 | $6,611 |
Brand drugs: 957 claims; generic drugs: 482 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bayan Mesmar $327 ($327 in general payments such as food, travel and fees) from 4 companies. The largest payer was Lilly USA, LLC with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.